Piper Sandler reiterates Overweight on Axsome Therapeutics, $258 target
Piper Sandler reiterated an Overweight rating on Axsome Therapeutics and set a $258.00 price target, implying 20.4% upside versus the Sep 17 close of $214.28.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.